Science and Enterprise

Category: Hiring/layoffs

  • Novartis to Restructure, Cut 1,960 U.S. Jobs

    The Swiss company Novartis Pharmaceuticals said on Friday it plans to reorganize its General Medicines division in the U.S. resulting in a loss of 1,960 jobs. The company said it expects the job cuts to take place in the second quarter of 2012. Novartis plans to reduce its General Medicines field workforce by 1,630 jobs…

  • Geron Halts Embryonic Stem Cell Research, Clinical Trial

    Geron Corporation, a biotechnology company in Menlo Park, California, says it has discontinued its development of therapies based on human embryonic stem cells to focus on cancer drugs. The immediate results of its decision are to end a clinical trial of its stem cell drug on patients with spinal cord injuries — the first clinical…

  • Novartis to Cut Jobs in U.S., Switzerland; Add Jobs in Asia

    In its third-quarter financial report released today, the Swiss pharmaceutical company Novartis AG said it would cut some 2,000 jobs in Switzerland and the U.S., but add 700 jobs in China and India. The cuts were announced at the same time the company said it recorded gains in third quarter sales of 12 percent and…

  • New On Technorati: Friendly to What Business?

    High paying jobs are being created in large numbers right here in the U.S., and in places where the so-called experts say they’re not supposed to happen. If states want the big bucks from big brains and the benefits they bring, then they need to make the work being done and people doing the work…

  • Semiconductor Companies to Invest $4.4B in New York R&D

    Five semiconductor developers said today they will make a joint investment of $4.4 billion over the next five years to develop new computer chip technologies in New York State. The companies include Intel Corporation, IBM, GlobalFoundries, Samsung, and Taiwan Semiconductor Manufacturing Company (TSMC). The investments will be made in current and upgraded facilities in Albany,…

  • Sandia Lab Contributes Nearly $1B to California Economy

    An analysis of economic output generated by Sandia National Laboratories shows the lab contributes nearly $1 billion to the California economy, particularly in and around its Livermore campus in the Bay Area. The report was prepared by the Center for Economic Development (CED) at California State University in Chico. The CED report defines economic output…

  • Pfizer to Build Research Labs in Cambridge, Mass.

    Pfizer Inc., the global pharmaceutical company based in New York, says it will build a new research facility in Cambridge, Massachusetts. The company expects the facility will employ a staff of 400, most in research or related positions. The new building will be located in Kendall Square, just north of the MIT campus. Pfizer says…

  • Insomnia Costs U.S. Employers Billions in Lost Productivity

    Researchers from universities, hospitals, and companies in the U.S. and Europe calculated the lost productivity of Americans suffering from insomnia at an annual cost of $63.2 billion to employers. Their findings from the study, funded by the pharmaceutical company Merck, appear in the 1 September issue of the journal Sleep (paid subscription required). The team…

  • People Without Jobs and Insurance Skip Medicine, Health Care

    A report from the Commonwealth Fund in New York says the vast majority of people who lost both their jobs and health insurance in the past two years skipped needed health care or did not fill prescriptions because of the cost. The data for the study come from the Commonwealth Fund’s 2010 Biennial Health Insurance…

  • Roche to Build Canadian Pharmaceutical Development Center

    Roche Canada, a division of the global drug company based in Switzerland, says it will build a new pharmaceutical development center at its current site in Mississauga, Ontario near Toronto. The new center, says Roche, involves an investment of $190 million over the next five years, and will add 200 skilled staff. The new center…